Supernus Pharmaceuticals Inc.

10/31/2024 | Press release | Distributed by Public on 10/31/2024 14:20

Supernus Presents Promising Data from Open Label Phase 2a Study of SPN 820 Data in Major Depressive Disorder at Psych Congress 2024